Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.
Transcriptional gene silencing (TGS) of mammalian genes can be induced by short interfering RNA (siRNA) targeting promoter regions. We previously reported potent TGS of HIV-1 by siRNA (PromA), which targets tandem NF-κB motifs within the viral 5'LTR. In this study, we screened a siRNA panel with the aim of identifying novel 5'LTR targets, to provide multiplexing potential with enhanced viral silencing and application toward developing alternate therapeutic strategies. Systematic examination identified a novel siRNA target, si143, confirmed to induce TGS as the silencing mechanism. TGS was prolonged with virus suppression >12 days, despite a limited ability to induce post- TGS. Epigenetic changes associated with silencing were suggested by partial reversal by histone deacetylase inhibitors and confirmed by chromatin immunoprecipitation analyses, which showed induction of H3K27me3 and H3K9me3, reduction in H3K9Ac, and recruitment of argonaute-1, all characteristic marks of heterochromatin and TGS. Together, these epigenetic changes mimic those associated with HIV-1 latency. Further, robust resistance to reactivation was observed in the J-Lat 9.2 cell latency model, when transduced with shPromA and/or sh143. These data support si/shRNA-mediated TGS approaches to HIV-1 and provide alternate targets to pursue a functional cure, whereby the viral reservoir is locked in latency following antiretroviral therapy cessation.
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
Chantelle
C
Ahlenstiel
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
Catalina
C
Mendez
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
Steven T H
ST
Lim
Immunovirology Laboratory, St. Vincent's Centre for Applied Medical Research, Darlinghurst, New South Wales, Australia.
Katherine
K
Marks
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
Stuart
S
Turville
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
David A
DA
Cooper
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.|Immunovirology Laboratory, St. Vincent's Centre for Applied Medical Research, Darlinghurst, New South Wales, Australia.
Anthony D
AD
Kelleher
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.|Immunovirology Laboratory, St. Vincent's Centre for Applied Medical Research, Darlinghurst, New South Wales, Australia.
Kazuo
K
Suzuki